Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma
- 1 April 1981
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 100 (1), 113-116
- https://doi.org/10.1007/bf00405909
Abstract
Ten patients with advanced renal carcinoma were treated by ifosfamide (50–60 mg/kg/dayx5 days). The treatment was repeated every 4 weeks and continued until progression appeared. Two patients came into partial remission, two had subjective improvement, and six did not respond. Seven patients developed acute psychopathological symptoms during the first ifosfamide-cycle. Five patients had visual and paranoid hallucinations, four patients were completely confused. Follow-up for up to 10 weeks showed a persisting organic brain syndrome in five patients.Keywords
This publication has 6 references indexed in Scilit:
- [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].1978
- [Clinical experience with the cytostatic drug ifosfamide].1977
- [Experience with fractionate massive-dose Ifosfamid therapy of generalized malignant tumors].1975
- Pharmacokinetics of ifosfamideClinical Pharmacology & Therapeutics, 1975
- Clinical pharmacology of isophosphamideClinical Pharmacology & Therapeutics, 1974
- Chemotherapy of adenocarcinoma of the kidneyCancer, 1973